Literature DB >> 23152532

Significant reductions in Gag-protease-mediated HIV-1 replication capacity during the course of the epidemic in Japan.

Shigeru Nomura1, Noriaki Hosoya, Zabrina L Brumme, Mark A Brockman, Tadashi Kikuchi, Michiko Koga, Hitomi Nakamura, Tomohiko Koibuchi, Takeshi Fujii, Jonathan M Carlson, David Heckerman, Ai Kawana-Tachikawa, Aikichi Iwamoto, Toshiyuki Miura.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) evolves rapidly in response to host immune selection pressures. As a result, the functional properties of HIV-1 isolates from earlier in the epidemic may differ from those of isolates from later stages. However, few studies have investigated alterations in viral replication capacity (RC) over the epidemic. In the present study, we compare Gag-Protease-associated RC between early and late isolates in Japan (1994 to 2009). HIV-1 subtype B sequences from 156 antiretroviral-naïve Japanese with chronic asymptomatic infection were used to construct a chimeric NL4-3 strain encoding plasma-derived gag-protease. Viral replication capacity was examined by infecting a long terminal repeat-driven green fluorescent protein-reporter T cell line. We observed a reduction in the RC of chimeric NL4-3 over the epidemic, which remained significant after adjusting for the CD4(+) T cell count and plasma virus load. The same outcome was seen when limiting the analysis to a single large cluster of related sequences, indicating that our results are not due to shifts in the molecular epidemiology of the epidemic in Japan. Moreover, the change in RC was independent of genetic distance between patient-derived sequences and wild-type NL4-3, thus ruling out potential temporal bias due to genetic similarity between patient and historic viral backbone sequences. Collectively, these data indicate that Gag-Protease-associated HIV-1 replication capacity has decreased over the epidemic in Japan. Larger studies from multiple geographical regions will be required to confirm this phenomenon.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23152532      PMCID: PMC3554148          DOI: 10.1128/JVI.02122-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  96 in total

1.  Human immunodeficiency virus type 1 expressing the lamivudine-associated M184V mutation in reverse transcriptase shows increased susceptibility to adefovir and decreased replication capability in vitro.

Authors:  M D Miller; K E Anton; A S Mulato; P D Lamy; J M Cherrington
Journal:  J Infect Dis       Date:  1999-01       Impact factor: 5.226

2.  Identification of a novel HLA-A24-restricted cytotoxic T-lymphocyte epitope derived from HIV-1 Gag protein.

Authors:  Y Ikeda-Moore; H Tomiyama; M Ibe; S Oka; K Miwa; Y Kaneko; M Takiguchi
Journal:  AIDS       Date:  1998-10-22       Impact factor: 4.177

3.  Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques.

Authors:  T Matano; R Shibata; C Siemon; M Connors; H C Lane; M A Martin
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

4.  Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.

Authors:  P Borrow; H Lewicki; X Wei; M S Horwitz; N Peffer; H Meyers; J A Nelson; J E Gairin; B H Hahn; M B Oldstone; G M Shaw
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

5.  Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection.

Authors:  D A Price; P J Goulder; P Klenerman; A K Sewell; P J Easterbrook; M Troop; C R Bangham; R E Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

6.  Is the clinical course of HIV-1 changing? Cohort study.

Authors:  A Sinicco; R Fora; R Raiteri; M Sciandra; G Bechis; M M Calvo; P Gioannini
Journal:  BMJ       Date:  1997-04-26

7.  In vitro replication kinetics of human immunodeficiency virus type 1 (HIV-1) variants in relation to virus load in long-term survivors of HIV-1 infection.

Authors:  H Blaak; M Brouwer; L J Ran; F de Wolf; H Schuitemaker
Journal:  J Infect Dis       Date:  1998-03       Impact factor: 5.226

8.  Loss of viral fitness associated with multiple Gag and Gag-Pol processing defects in human immunodeficiency virus type 1 variants selected for resistance to protease inhibitors in vivo.

Authors:  V Zennou; F Mammano; S Paulous; D Mathez; F Clavel
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

9.  Temporal trends in the progression of human immunodeficiency virus disease in a cohort of drug users.

Authors:  M P Webber; E E Schoenbaum; M N Gourevitch; D Buono; C J Chang; R S Klein
Journal:  Epidemiology       Date:  1998-11       Impact factor: 4.822

10.  Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa.

Authors:  L Dorrell; T Dong; G S Ogg; S Lister; S McAdam; T Rostron; C Conlon; A J McMichael; S L Rowland-Jones
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more
  9 in total

1.  Population-Level Immune-Mediated Adaptation in HIV-1 Polymerase during the North American Epidemic.

Authors:  Natalie N Kinloch; Daniel R MacMillan; Anh Q Le; Laura A Cotton; David R Bangsberg; Susan Buchbinder; Mary Carrington; Jonathan Fuchs; P Richard Harrigan; Beryl Koblin; Margot Kushel; Martin Markowitz; Kenneth Mayer; M J Milloy; Martin T Schechter; Theresa Wagner; Bruce D Walker; Jonathan M Carlson; Art F Y Poon; Zabrina L Brumme
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

2.  Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence.

Authors:  Rebecca Payne; Maximilian Muenchhoff; Jaclyn Mann; Hannah E Roberts; Philippa Matthews; Emily Adland; Allison Hempenstall; Kuan-Hsiang Huang; Mark Brockman; Zabrina Brumme; Marc Sinclair; Toshiyuki Miura; John Frater; Myron Essex; Roger Shapiro; Bruce D Walker; Thumbi Ndung'u; Angela R McLean; Jonathan M Carlson; Philip J R Goulder
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-01       Impact factor: 11.205

3.  Pairwise growth competition assay for determining the replication fitness of human immunodeficiency viruses.

Authors:  Siriphan Manocheewa; Erinn C Lanxon-Cookson; Yi Liu; J Victor Swain; Jan McClure; Ushnal Rao; Brandon Maust; Wenjie Deng; Justine E Sunshine; Moon Kim; Morgane Rolland; James I Mullins
Journal:  J Vis Exp       Date:  2015-05-04       Impact factor: 1.355

4.  Discordant Impact of HLA on Viral Replicative Capacity and Disease Progression in Pediatric and Adult HIV Infection.

Authors:  Emily Adland; Paolo Paioni; Christina Thobakgale; Leana Laker; Luisa Mori; Maximilian Muenchhoff; Anna Csala; Margaret Clapson; Jacquie Flynn; Vas Novelli; Jacob Hurst; Vanessa Naidoo; Roger Shapiro; Kuan-Hsiang Gary Huang; John Frater; Andrew Prendergast; Julia G Prado; Thumbi Ndung'u; Bruce D Walker; Mary Carrington; Pieter Jooste; Philip J R Goulder
Journal:  PLoS Pathog       Date:  2015-06-15       Impact factor: 6.823

5.  Genotypic and functional impact of HIV-1 adaptation to its host population during the North American epidemic.

Authors:  Laura A Cotton; Xiaomei T Kuang; Anh Q Le; Jonathan M Carlson; Benjamin Chan; Denis R Chopera; Chanson J Brumme; Tristan J Markle; Eric Martin; Aniqa Shahid; Gursev Anmole; Philip Mwimanzi; Pauline Nassab; Kali A Penney; Manal A Rahman; M-J Milloy; Martin T Schechter; Martin Markowitz; Mary Carrington; Bruce D Walker; Theresa Wagner; Susan Buchbinder; Jonathan Fuchs; Beryl Koblin; Kenneth H Mayer; P Richard Harrigan; Mark A Brockman; Art F Y Poon; Zabrina L Brumme
Journal:  PLoS Genet       Date:  2014-04-24       Impact factor: 5.917

6.  Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals.

Authors:  Keiko Sakai; Takayuki Chikata; Zabrina L Brumme; Chanson J Brumme; Hiroyuki Gatanaga; Hiroyuki Gatanag; Shinichi Oka; Masafumi Takiguchi
Journal:  Retrovirology       Date:  2015-11-19       Impact factor: 4.602

7.  Impact of HLA selection pressure on HIV fitness at a population level in Mexico and Barbados.

Authors:  Claudia I Juarez-Molina; Rebecca Payne; Maribel Soto-Nava; Santiago Avila-Rios; Humberto Valenzuela-Ponce; Emily Adland; Ellen Leitman; Jacqui Brener; Maximilian Muenchhoff; Songee Branch; Clive Landis; Gustavo Reyes-Teran; Philip Goulder
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

Review 8.  Role of HLA Adaptation in HIV Evolution.

Authors:  Henrik N Kløverpris; Alasdair Leslie; Philip Goulder
Journal:  Front Immunol       Date:  2016-01-18       Impact factor: 7.561

9.  Rapid HIV-1 Disease Progression in Individuals Infected with a Virus Adapted to Its Host Population.

Authors:  Jiro Katoh; Ai Kawana-Tachikawa; Akihisa Shimizu; Dayong Zhu; Chungyong Han; Hitomi Nakamura; Michiko Koga; Tadashi Kikuchi; Eisuke Adachi; Tomohiko Koibuchi; George F Gao; Zabrina L Brumme; Aikichi Iwamoto
Journal:  PLoS One       Date:  2016-03-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.